Stock EXEL EXELIXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Exelixis, Inc.

Equities

EXEL

US30161Q1040

Market Closed - Nasdaq
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
21.7 USD +4.30% Intraday chart for Exelixis, Inc. +5.47% -9.57%
May. 31 Exelixis Insider Bought Shares Worth $8,733,955, According to a Recent SEC Filing MT
May. 20 Exelixis Settles Cabometyx Patent Litigation with Cipla MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
EXELIXIS, INC. Stock Exelixis, Inc.
 6.32B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. EXEL Stock
  4. Charts Exelixis, Inc.
  5. Sector Chart